Itoco Inc
Itoco Inc. engages in the processing, production, and distribution of medical cannabis products. The company was formerly known as Itoco Mining Corporation and changed its name to Itoco Inc. in May 2018. Itoco Inc. is based in Reno, Nevada.
Itoco Inc (ITMC) - Net Assets
Latest net assets as of September 2023: $-979.56K USD
Based on the latest financial reports, Itoco Inc (ITMC) has net assets worth $-979.56K USD as of September 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.19 Million) and total liabilities ($2.17 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-979.56K |
| % of Total Assets | -82.32% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Itoco Inc - Net Assets Trend (2008–2022)
This chart illustrates how Itoco Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Itoco Inc (2008–2022)
The table below shows the annual net assets of Itoco Inc from 2008 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $-253.08K | +84.39% |
| 2021-12-31 | $-1.62 Million | +1.54% |
| 2020-12-31 | $-1.65 Million | +22.31% |
| 2019-12-31 | $-2.12 Million | -119.47% |
| 2018-12-31 | $-965.70K | +50.53% |
| 2017-12-31 | $-1.95 Million | -636.43% |
| 2016-12-31 | $-265.09K | +35.63% |
| 2015-12-31 | $-411.81K | -2824.16% |
| 2014-12-31 | $-14.08K | +99.58% |
| 2009-12-31 | $-3.34 Million | +46.98% |
| 2008-12-31 | $-6.29 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Itoco Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1506896600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $225.02K | % |
| Other Components | $14.66 Million | % |
| Total Equity | $-253.08K | 100.00% |
Itoco Inc Competitors by Market Cap
The table below lists competitors of Itoco Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ANBC INC
PINK:SYUP
|
$46.11 |
|
MONTEGO RESOURCES INC.
F:4MO
|
$46.26 |
|
CYIOS Corporation
PINK:CYIO
|
$46.38 |
|
National Healthcare Logistics Inc
PINK:NHLG
|
$46.42 |
|
UPDC REAL ESTATE INVESTMENT TRUST
XNSA:UPDCREIT
|
$46.01 |
|
Man Shing Agricultural Holdings Inc
PINK:MSAH
|
$45.72 |
|
WhereverTV Broadcasting Corporation
PINK:TVTV
|
$45.46 |
|
NB Distressed Debt New Glb
LSE:NBDG
|
$45.41 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Itoco Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -1,621,265 to -253,079, a change of 1,368,186.
- Net loss of 1,820,000 reduced equity.
- Other comprehensive income increased equity by 10.
- Other factors increased equity by 3,188,176.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.82 Million | -719.14% |
| Other Comprehensive Income | $10.00 | +0.0% |
| Other Changes | $3.19 Million | +1259.76% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Itoco Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $0.09 | $0.01 | x |
| 2009-12-31 | $-145.09 | $0.01 | x |
| 2014-12-31 | $-0.01 | $0.01 | x |
| 2015-12-31 | $-0.06 | $0.01 | x |
| 2016-12-31 | $-0.03 | $0.01 | x |
| 2017-12-31 | $-5.98 | $0.01 | x |
| 2018-12-31 | $-0.01 | $0.01 | x |
| 2019-12-31 | $-0.02 | $0.01 | x |
| 2020-12-31 | $-0.01 | $0.01 | x |
| 2021-12-31 | $-0.01 | $0.01 | x |
| 2022-12-31 | $0.00 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Itoco Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (258.49%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 3360.41% | 19.54% | 171.95x | 1.00x | $1.32 Million |
| 2009 | 0.00% | -166.12% | 0.44x | 0.00x | $-2.08 Million |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.95K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.81 |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-48.24K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-352.82K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-481.49K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.54 Million |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.60 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.76 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.25 Million |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $124.13K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.79 Million |
Industry Comparison
This section compares Itoco Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Itoco Inc (ITMC) | $-979.56K | 3360.41% | N/A | $46.05 |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |